The Use of Cannabis for Headache Disorders
Authors:
Open Access
- 1 January 2017
- journal article
- review article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 2 (1) , 61-71
Abstract
Headache disorders are common, debilitating, and, in many cases, inadequately managed by existing treatments. Although clinical trials of cannabis for neuropathic pain have shown promising results, there has been limited research on its use, specifically for headache disorders. This review considers historical prescription practices, summarizes the existing reports on the use of cannabis for headache, and examines the preclinical literature exploring the role of exogenous and endogenous cannabinoids to alter headache pathophysiology. Currently, there is not enough evidence from well-designed clinical trials to support the use of cannabis for headache, but there are sufficient anecdotal and preliminary results, as well as plausible neurobiological mechanisms, to warrant properly designed clinical trials. Such trials are needed to determine short- and long-term efficacy for specific headache types, compatibility with existing treatments, optimal administration practices, as well as potential risks.Keywords
This publication has 78 references indexed in Scilit:
- Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trialThe Journal of Headache and Pain, 2012
- Medical Marijuana: Clearing Away the SmokeThe Open Neurology Journal, 2012
- Effects of anandamide in migraine: data from an animal modelThe Journal of Headache and Pain, 2011
- An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in CaliforniaJournal of Drug Policy Analysis, 2011
- Migraine and psychiatric comorbidity: a review of clinical findingsThe Journal of Headache and Pain, 2011
- Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokersDrug and Alcohol Dependence, 2010
- Endocannabinoids Suppress Excitatory Synaptic Transmission to Dorsal Raphe Serotonin Neurons through the Activation of Presynaptic CB1 ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Variations in the cannabinoid receptor 1 gene predispose to migraineNeuroscience Letters, 2009
- Chronic cluster headache: a French clinical descriptive studyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular NeuronsThe Journal of Pharmacology and Experimental Therapeutics, 2007